| NCT ID | NCT06720142 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Santiago Lozano-Calderon |
| Condition | Cancer of Bone |
| Study Type | OBSERVATIONAL |
| Enrollment | 10 participants |
| Start Date | 2025-03-17 |
| Primary Completion | 2027-03-17 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10 participants in total. It began in 2025-03-17 with a primary completion date of 2027-03-17.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Mg OSTEOCRETE is a bone substitute used to fill a defect in bone caused by excision of a tumor, orthopaedic hardware that has become loosened, or a trauma-related condition. The aim of this study is to determine the amount of time it takes for bone to heal after treatment with Mg OSTEOCRETE, and to better understand the efficacy of this treatment through clinical and patient-reported outcomes.
Eligibility Criteria
Inclusion Criteria: * 18 years of age and older on the day of surgery * has received or will receive Mg OSTEOCRETE as a component of their treatment at this institution in accordance with Instructions for Use for the implanted product * Mg OSTEOCRETE is indicated for one of the following reasons: 1. as a bone void filler following bone tumor resection, or; 2. as an augment for defects causing aseptic loosening of orthopaedic implants, or; 3. to help substitute bone for trauma-related conditions Exclusion Criteria: * any contraindication as per Instructions for Use for Mg OSTEOCRETE
Contact & Investigator
Santiago A Lozano-Calderon, MD, PhD
PRINCIPAL INVESTIGATOR
Massachusetts General Hospital
Frequently Asked Questions
Who can join the NCT06720142 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer of Bone. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06720142 currently recruiting?
Yes, NCT06720142 is actively recruiting participants. Contact the research team at shalur@mgh.harvard.edu for enrollment information.
Where is the NCT06720142 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT06720142 clinical trial?
NCT06720142 is sponsored by Santiago Lozano-Calderon. The principal investigator is Santiago A Lozano-Calderon, MD, PhD at Massachusetts General Hospital. The trial plans to enroll 10 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.